Clinical Trials Directory

Trials / Terminated

TerminatedNCT03635671

Diabetic Retinopathy and Subclinical Signs of Disease Transition

Status
Terminated
Phase
Study type
Observational
Enrollment
5 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The prevalence of diabetes mellitus (DM) is increasing worldwide. Diabetic retinopathy is the most prevalent complication of DM and a leading cause of visual impairment. Some factors are known to temporarily aggravate or improve diabetic retinopathy, but underlying pathophysiologic factors are still unknown. High-resolution imaging techniques of the retina and its supplying vascular networks now allow novel insight to subtle changes that cannot be appreciated in standard fundus examination. In detail, the investigators image study patients with optical coherence tomography (OCT) - technology, that provides morphological information of retinal structure and the supplying vessels in a non-invasive way. Retinal layer thickness as well as capillary density will be quantified and followed in patients that are in a critical period of disease transition to better understand the process of diabetic retinopathy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOptical Coherence Tomography AngiographyRetinal scans will be acquired at each follow up visit

Timeline

Start date
2018-09-01
Primary completion
2019-07-15
Completion
2019-07-15
First posted
2018-08-17
Last updated
2019-08-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03635671. Inclusion in this directory is not an endorsement.